EXPERT SPEAKER FACULTY

Andrew Steinsapir

Acting Chief Technology Officer

Apertura Gene Therapy

April Sena

Vice President, Technical Operations

Life Edit Therapeutics

Ashutosh Gupta

Director - Drug Substance Process Development & Manufacturing

Kiniksa Pharmaceuticals

Ishtiaq Khaliq

Gene Therapy & Molecular Biology Sciences Lead

UCB S.A.

Jingying Xu

Director - Regulatory Affairs Chemistry Manufacturing & Controls

Kite, a Gilead Company

Jorge Santiago-Ortiz

Senior Director - Chemistry, Manufacturing, & Controls

Apertura Gene Therapy

Kathy Nguyen

Engineer IV

Takeda Pharmaceutical Co. Ltd.

Kok Seong Lim

Analytical Sciences & Quality Control Expert

Independent Expert

Matthew Weaver

Senior Director - Chemistry, Manufacturing & Control Developability

Spirovant Sciences

Michael Datillo

Senior Investigator, Lentiviral Vector Manufacturing Excellence

Johnson & Johnson Services, Inc

Michael DiBiasio-White

Senior Scientist

Ring Therapeutics

Rekha Iyengar

Senior Scientist Upstream Vector Development

Stanford University

Tony Chikere

Director, Vector Process Development

Sangamo Therapeutics

Valerie Ng

Associate Director - Regulatory Affairs, Chemistry, Manufacturing & Controls

Kite, a Gilead Company

Ying Cai

Executive Director - Manufacturing Sciences & Technology

Ultragenyx Pharmaceutical Inc

Yuanli Song

Associate Director

Sanofi

REGISTER
SEE FULL AGENDA
PARTNER